home / stock / cadl / cadl articles

CADL Articles, Candel Therapeutics Inc. - From 04/11/24

Stock Information
Company Name: Candel Therapeutics Inc.
Stock Symbol: CADL
Market: NASDAQ
Website: candeltx.com
Menu
CADL CADL Quote CADL Short CADL News CADL Articles CADL Message Board
Get CADL Alerts

News, Short Squeeze, Breakout and More Instantly...
What's Going On With Candel Therapeutics Stock? | Benzinga

Candel Therapeutics, Inc. (NASDAQ:CADL) shares are trading higher Thursday after the company received FDA orphan drug designation for CAN-2409 for ...
What's Going On With Candel Therapeutics Stock On Friday? | Benzinga

Friday, Candel Therapeutics Inc (NASDAQ:CADL) shares are trading higher on heavy volume with a session volume of 7.89 million versus the ...

Ford, Candel Therapeutics, Nvidia, Palantir, Tesla: Why These 5 Stocks Are On Investors' Radars Today | Benzinga

The U.S. stock market experienced a downturn on Thursday, with the Dow Jones index falling by 1.35% to 38,596.98. The NASDAQ and the S&P 500 al...

Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results | Benzinga

U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.5...
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-qua...

Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings | Benzinga

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 150 points on Thursday. The Dow traded up 0.49% to 39...

After Brain Cancer Data, Candel Therapeutics' Shares Good News From Pancreatic Cancer Study | Benzinga

Thursday, Candel Therapeutics Inc (NASDAQ:CADL) released updated interim survival data from the ongoing phase 2 trial of CAN-2409 plus va...
Micro-Cap Cancer Focused Candel Therapeutics Highlights Encouraging Data From Brain Tumor Immunotherapy | Benzinga

Thursday, Candel Therapeutics Inc (NASDAQ:CADL) announced the presentation of updated data from an ongoing phase 1b trial of its herpes s...

Candel Therapeutics Announces an Upcoming Presentation at the AACR Annual Meeting Unveiling New Cancer Immunotherapy Candidate | Benzinga

NEEDHAM, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical stage biopharmace...

Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results. Johnson Contr...
Previous 10 Next 10